Literature DB >> 22734283

Antibiotic impregnated cement spacer for salvage of diabetic osteomyelitis.

Eyal A Melamed1, Eli Peled.   

Abstract

BACKGROUND: Florid infection and osteomyelitis of the forefoot in patients with diabetic neuropathy often requires minor amputation, with risk of subsequent reulceration, reamputation, and patient dissatisfaction. We investigated use of an antibiotic-impregnated cement spacer (ACS) to release antibiotic locally to resolve residual infection and to fill the cavity created by debridement.
METHODS: We report 23 cases of osteomyelitis and associated severe infection of forefoot joints in 20 consecutive patients, age 60.3 +/- 13.4 years. Antibiotic-impregnated cement, extensive meticulous debridement, and ACS placement to fill the gap were employed in all cases. Deep cultures were taken routinely. Fixation with Kirschner wires was used as necessary. Mean followup was 21.2 +/- 10.2 months. A successful result was resolution of infection and wound healing to full skin closure without amputation.
RESULTS: Of 23 cases, 21 (91.3%) healed and two required toe amputation. ACS was left permanently in 10 patients, removed with arthrodesis in six, and removed without arthrodesis in five. One patient recovered but subsequently underwent transtibial amputation due to infection of a different site.
CONCLUSION: Severe infection associated with osteomyelitis of the foot in diabetic patients was successfully treated with extensive debridement and use of ACS, which filled the void created by debridement. Amputation was avoided in most patients. This procedure allowed extensive debridement through filling large voids with ACS, with prolonged antibiotic release.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734283     DOI: 10.3113/FAI.2012.0213

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  7 in total

Review 1.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

2.  Calcium phosphate nanoparticles: a future therapeutic platform for the treatment of osteomyelitis?

Authors:  Tejal A Desai; Vuk Uskoković
Journal:  Ther Deliv       Date:  2013-06

3.  Antibiotic-impregnated cement spacer as definitive management for osteomyelitis.

Authors:  Xu-Sheng Qiu; Xin Zheng; Hong-fei Shi; Yan-cheng Zhu; Xia Guo; Hai-jun Mao; Guang-yue Xu; Yi-xin Chen
Journal:  BMC Musculoskelet Disord       Date:  2015-09-14       Impact factor: 2.362

4.  The Fate of Antibiotic Impregnated Cement Space in Treatment for Forefoot Osteomyelitis.

Authors:  Inha Woo; Jeongjin Park; Hyungyu Seok; Tae-gon Kim; Jun Sung Moon; Seung Min Chung; Chul Hyun Park
Journal:  J Clin Med       Date:  2022-04-01       Impact factor: 4.241

Review 5.  Local Antibiotic Delivery Systems in Diabetic Foot Osteomyelitis: A Brief Review.

Authors:  Christos Chatzipapas; Makrina Karaglani; Nikolaos Papanas; Konstantinos Tilkeridis; Georgios I Drosos
Journal:  Rev Diabet Stud       Date:  2021-11-01

6.  Doped Halloysite Nanotubes for Use in the 3D Printing of Medical Devices.

Authors:  Jeffery A Weisman; Udayabhanu Jammalamadaka; Karthik Tappa; David K Mills
Journal:  Bioengineering (Basel)       Date:  2017-12-15

7.  Effect of Induced Membrane Formation Followed by Polymethylmethacrylate Implantation on Diabetic Foot Ulcer Healing When Revascularization Is Not Feasible.

Authors:  Chao Liu; Jia-Xing You; Yi-Xin Chen; Wei-Fen Zhu; Ying Wang; Pan-Pan Lv; Feng Zhao; Hong-Ye Li; Lin Li
Journal:  J Diabetes Res       Date:  2019-11-19       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.